C-BRAIN taps AI to accelerate Alzheimer’s research

C-BRAIN is working with NVIDIA to address bottlenecks in Alzheimer’s research, including fragmented datasets and the slow synthesis of scientific findings. Led by Dr. Randall Bateman, the consortium brings together 18 member institutions across academia, philanthropy, pharmaceutical companies and research organizations. Its approach draws on unpublished findings, negative results and governed proprietary data that have not been publicly accessible to researchers or AI tools.

To protect patient privacy and institutional control, C-BRAIN combines secure centralized systems with federated methods that allow models to learn from data without moving it outside institutions. Researchers have built OpenScientist, an open source AI co-scientist that generates hypotheses, runs analyses and produces auditable insights, and InsightEngine, which tests hypotheses against scientific literature and checks claims against evidence. Published case studies found OpenScientist completed analyses in minutes that domain scientists estimated would take weeks to months.

The consortium currently reaches over 200 research groups and is working to incorporate NVIDIA BioNeMo and MONAI into its research pipelines. Its longer-term goal is a multimodal biological foundation model spanning neuroimaging, multi-omics, fluid biomarkers and longitudinal clinical measures. C-BRAIN aims to use that broader evidence base to identify causal mechanisms of brain aging and Alzheimer’s disease and develop testable scientific principles.